M&A

Stada's suitors, shot down by investors, rally with improved takeover bid
Fierce Pharma
Wed, 07/12/17 - 09:51 am
Stada
M&A
Stalled U.S. tax reform, high deal premiums can't hobble pharma's M&A pace: expert
Fierce Pharma
Tue, 07/11/17 - 11:49 pm
tax reform
M&A
Sanofi gets a flu vaccines booster with $650M-plus Protein Sciences buy
Fierce Pharma
Tue, 07/11/17 - 11:15 am
Sanofi
Sanofi Pasteur
M&A
Protein Sciences
flu vaccine
vaccines
Medtech Mergers Surge Again
Seeking Alpha
Mon, 07/10/17 - 11:12 pm
devices
M&A
Abbott Labs
Cutera
St. Jude Medical
Allergan
Syneron
JNJ
Alere shareholders approve amended $5.3B Abbott merger
Mass Device
Mon, 07/10/17 - 11:11 am
devices
M&A
Abbott Labs
Alere
shareholders
How Shrewd of a Dealmaker Is Gilead Sciences? Just Look at Its Last 7 Acquisitions
Motley Fool
Sun, 07/9/17 - 11:45 am
Gilead Sciences
M&A
CV Therapeutics
CGI Pharma
Arresto Biosciences
Calistoga Pharmaceuticals
Pharmasset
YM BioSciences
EpiTherapeutics
Acer aims for public listing through reverse merger
BioPharma Dive
Sun, 07/9/17 - 11:35 am
Acer
reverse merger
M&A
Opexa Therapeutics
Inside JNJ’s Inorganic Strategy in Medical Devices: The Latest Acquisitions
Market Realist
Fri, 07/7/17 - 10:02 am
JNJ
devices
M&A
Sentio
Abbott Medical Optics
Neuravi
NuPak Medical acquired by largest customer Katena
Medical Design and Outsourcing
Fri, 07/7/17 - 08:32 am
NuPak Medical
devices
CMOs
Katena
M&A
3 Mid-Cap Biotech Stocks That May Be Red-Hot Takeover Candidates
Motley Fool
Wed, 07/5/17 - 07:08 pm
biotech
M&A
Exelixis
Portola Pharmaceuticals
Intercept Pharmaceuticals
Gilead's best M&A option? It's not oncology—it's Vertex, analyst insists
Fierce Pharma
Sat, 07/1/17 - 09:22 am
Gilead Sciences
M&A
Vertex Pharmaceuticals
Gilead buy Vertex? A golden oldie in the M&A buzz circuit gets fresh air time
Endpoints
Fri, 06/30/17 - 10:48 am
Gilead Sciences
Vertex Pharmaceuticals
M&A
Medtech M&A: The 10 biggest deals so far in 2017
Mass Device
Thu, 06/29/17 - 09:45 pm
devices
M&A
Abbott Labs
St. Jude Medical
Edwards Lifesciences
Valtech Cardio
Hologic
Cynosure
JNJ
Teleflex
Vascular Soltions
Cardinal Health
Medtronic
Becton Dickinson
CR Bard
Boston Scientific
Symetis
Integra LifeSciences
Codman Neuro
Stryker
Novadaq
J&J’s DePuy Synthes buys spinal tech dev Sentio
Mass Device
Tue, 06/27/17 - 11:54 pm
JNJ
DePuy Synthes
M&A
Sentio
devices
2 Pharma Buyout Targets That May Surprise You
Motley Fool
Tue, 06/27/17 - 09:46 am
Biogen
Bristol-Myers Squibb
M&A
MS
multiple sclerosis
immuno-oncology
Is Clovis Oncology A Takeover Candidate?
Seeking Alpha
Mon, 06/26/17 - 04:54 pm
Clovis Oncology
M&A
rucaparib
PARP inhibitors
Portola Pharmaceuticals' FDA Nod Could Spark M&A Interest
Motley Fool
Sun, 06/25/17 - 10:46 am
Portola Pharmaceuticals
FDA
M&A
Bevyxxa
What we know from BIO2017
BioPharma Dive
Fri, 06/23/17 - 11:30 am
BIO2017
M&A
Novartis
Novo Nordisk
Seattle Genetics
ImmunoCellular Therapeutics
Report: Biopharma dealmaking set to level off
BioPharma Dive
Wed, 06/21/17 - 11:43 pm
M&A
Analysts: Stryker might not be the only bidder for Novadaq
Endpoints
Tue, 06/20/17 - 08:54 am
Stryker
Novadaq
devices
M&A

Pages